Icon

ALIQOPA (nda209936)- (60MG/VIAL)

COPANLISIB DIHYDROCHLORIDE BAYER HEALTHCARE
60MG/VIAL
No No
2032-Mar-29 2022-Sep-14
2024-Sep-14 None
None No
ALIQOPA is a kinase inhibitor indicated for the treatment of adult patients with relapsed follicular lymphoma (FL) who have received at least two prior systemic therapies
0 0 0
Total Other Developers None
Drugs with Suitability No
60MG/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.